Body mass index and retinopathy in type 1 diabetic patients

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Kaštelan, Snježana ^a   Salopek Rabatić, Jasminka ^a   Tomić, Martina ^b   Gverović Antunica, Antonela ^c   Ljubić, Spomenka ^b   Kaštelan, Helena ^c   Novak, Branko ^b   Orešković, Darko ^d  

^a University of Zagreb School of Medicine   (Croatia)

^b University of Zagreb   (Croatia)

^c Dubrovnik General Hospital   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; EYE EXAMINATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MILD NONPROLIFERATIVE DIABETIC RETINOPATHY; MODERATE NONPROLIFERATIVE DIABETIC RETINOPATHY; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEVERE NONPROLIFERATIVE DIABETIC RETINOPATHY; SEVERE PROLIFERATIVE DIABETIC RETINOPATHY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VERY SEVERE NONPROLIFERATIVE DIABETIC RETINOPATHY; VERY SEVERE PROLIFERATIVE DIABETIC RETINOPATHY; WEIGHT REDUCTION;

EID: 84897759934     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/387919     Document Type: Article

References (66)

1. Melendez-Ramirez L. Y., Richards R. J., Cefalu W. T., Complications of type 1 diabetes. Endocrinology and Metabolism Clinics of North America 2010 39 3 625 640 2-s2.0-77955733717 10.1016/j.ecl.2010.05.009
2. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2009 32 supplement 1 S62 S67
3. Maahs D. M., West N. A., Lawrence J. M., Mayer-Davis E. J., Epidemiology of type 1 diabetes. Endocrinology and Metabolism Clinics of North America 2010 39 3 481 497 2-s2.0-77955735519 10.1016/j.ecl.2010.05.011
4. Forlenza G. P., Rewers M., The epidemic of type 1 diabetes: what is it telling us? Current Opinion in Endocrinology, Diabetes and Obesity 2011 18 4 248 251 2-s2.0-79960769096 10.1097/MED.0b013e32834872ce
5. Shaw J. E., Sicree R. A., Zimmet P. Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010 87 1 4 14 2-s2.0-73749083481 10.1016/j.diabres.2009.10.007
6. Roglic G., Unwin N., Bennett P. H., Mathers C., Tuomilehto J., Nag S., Connolly V., King H., The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005 28 9 2130 2135 2-s2.0-24144472565 10.2337/diacare.28.9.2130 (Pubitemid 41242456)
7. Moss S. E., Klein R., Klein B. E. K., The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998 105 6 998 1003 2-s2.0-0031807908 10.1016/S0161-6420(98)96025-0 (Pubitemid 28268322)
8. Aiello L. M., Perspectives on diabetic retinopathy. American Journal of Ophthalmology 2003 136 1 122 135 2-s2.0-0038016408 10.1016/S0002-9394(03)00219-8 (Pubitemid 36794505)
9. Diabetes Control, Diabetes Control and Complication Trial / Epidemiology of Diabetes Interventions and Complications Research Group, Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The New England Journal of Medicine 2000 342 6 381 389
10. Stratton I. M., Kohner E. M., Aldington S. J., Turner R. C., Holman R. R., Manley S. E., Matthews D. R., UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001 44 2 156 163 2-s2.0-0035134120 10.1007/s001250051594 (Pubitemid 32156199)
11. Kaštelan S., Tomić M., Pavan J., Orešković S., Maternal immune system adaptation to pregnancy-a potential influence on the course of diabetic retinopathy. Reproductive Biology and Endocrinology 2010 8, article 124
12. Kaštelan S., Tomić M., Salopek-Rabatić J., Pavan J., Lukenda A., Gotovac M., Žunec R., The association between the HLA system and retinopathy development in patients with type 1 diabetes mellitus. Collegium Antropologicum 2013 37 supplement 1 65 70
13. Davis M. D., Diabetic retinopathy: a clinical overview. Diabetes Care 1992 15 12 1844 1874 2-s2.0-0026469096
14. Tomić M., Ljubić S., Kaštelan S., Gverović Antunica A., Jazbec A., Poljičanin T., Inflammation, haemostatic disturbance and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators in Inflammation 2013 2013 10 818671 10.1155/2013/818671
15. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993 329 14 977 986 2-s2.0-0027370108 10.1056/ NEJM199309303291401 (Pubitemid 23307905)
16. Sjolie A. K., Stephenson J., Aldington S., Kohner E., Janka H., Stevens L., Fuller J., Retinopathy and vision loss in insulin-dependent diabetes in Europe: The EURODIAB IDDM Complications Study. Ophthalmology 1997 104 2 252 260 2-s2.0-0031018345 (Pubitemid 27088100)
17. Karamanos B., Porta M., Songini M., Metelko Z., Kerenyi Z., Tamas G., Rottiers R., Stevens L. K., Fuller J. H., Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia 2000 43 3 348 355 2-s2.0-0034118008 (Pubitemid 30163478)
18. Beulens J. W. J., Patel A., Vingerling J. R., Cruickshank J. K., Hughes A. D., Stanton A., Lu J., McG Thom S. A., Grobbee D. E., Stolk R. P., Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia 2009 52 10 2027 2036 2-s2.0-69949166204 10.1007/s00125-009-1457-x
19. Ismail-Beigi F., Craven T., Banerji M. A., Basile J., Calles J., Cohen R. M., Cuddihy R., Cushman W. C., Genuth S., Grimm R. H. Jr., Hamilton B. P., Hoogwerf B., Karl D., Katz L., Krikorian A., O'Connor P., Pop-Busui R., Schubart U., Simmons D., Taylor H., Thomas A., Weiss D., Hramiak I., Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. The Lancet 2010 376 9739 419 430 2-s2.0-77955585592 10.1016/S0140-6736(10)60576-4
20. Kaštelan S., Tomić M., Gverović Antunica A., Ljubić S., Salopek-Rabatić J., Karabatić M., Body mass index-a risk factor for retinopathy in type 2 diabetic patients. Mediators of Inflammation 2013 2013 8 436329 10.1155/2013/436329
21. Chaturvedi N., Fuller J. H., Jarrett R. J., Keen H., Morrish N. J., Watkins P. J., Teuscher A., Teuscher T., Studer P. P., Diem P., Czyzyk A., Janeczko D., Kopczynski J., Raskovic M., Schliack V., Ratzmann K. P., Aganovic I., Skrabolo A., Stavljenic A., Mortality risk by body weight and weight change in people with NIDDM: The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care 1995 18 6 766 774 2-s2.0-0029043436
22. Henricsson M., Nyström L., Blohmé G., Östman J., Kullberg C., Svensson M., Schölin A., Arnqvist H. J., Björk E., Bolinder J., Eriksson J. W., Sundkvist G., The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003 26 2 349 354 2-s2.0-0038525261 10.2337/diacare.26.2.349 (Pubitemid 36929054)
23. UK Prospective Diabetes Study (UKPDS) Group, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet 1998 352 9131 854 865 2-s2.0-0032511566 10.1016/S0140-6736(98)07037-8 (Pubitemid 28416719)
24. van Leiden H. A., Dekker J. M., Moll A. C., Nijpels G., Heine R. J., Bouter L. M., Stehouwer C. D. A., Polak B. C. P., Risk factors for incident retinopathy in a diabetic and nondiabetic population: The Hoorn Study. Archives of Ophthalmology 2003 121 2 245 251 2-s2.0-0037314210 (Pubitemid 36184039)
25. Dirani M., Xie J., Fenwick E., Benarous R., Rees G., Wong T. Y., Lamoureux E. L., Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Investigative Ophthalmology & Visual Science 2011 52 7 4416 4421 2-s2.0-80052341866
26. Zhang L., Krzentowski G., Albert A., Lefebvre P. J., Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001 24 7 1275 1279 2-s2.0-0035405824 (Pubitemid 33716411)
27. Li X., Wang Z., Prevalence and incidence of retinopathy in elderly diabetic patients receiving early diagnosis and treatment. Experimental and Therapeutic Medicine 2013 5 5 1393 1396
28. De Block C. E. M., De Leeuw I. H., Van Gaal L. F., Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care 2005 28 7 1649 1655 2-s2.0-24944459905 10.2337/diacare.28.7.1649 (Pubitemid 41340904)
29. Klein R., Klein B. E. K., Moss S. E., Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Archives of Internal Medicine 1997 157 6 650 656 2-s2.0-0030945163 (Pubitemid 27133195)
30. Klein R., Klein B. E., Moss S. E., Davis M. D., DeMets D. L., The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Archives of Ophthalmology 1984 102 4 527 532 2-s2.0-0021191759 (Pubitemid 14127839)
31. Lim L. S., Shyong Tai E., Mitchell P., Wang J. J., Tay W. T., Lamoureux E., Wong T. Y., C-reactive protein, body mass index, and diabetic retinopathy. Investigative Ophthalmology and Visual Science 2010 51 9 4458 4463 2-s2.0-77957339847 10.1167/iovs.09-4939
32. Raman R., Rani P. K., Gnanamoorthy P., Sudhir R. R., Kumaramanikavel G., Sharma T., Association of obesity with diabetic retinopathy: sankara nethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS Report no. 8). Acta Diabetologica 2010 47 3 209 215 2-s2.0-77955663714 10.1007/s00592-009-0113-8
33. Dowse G. K., Humphrey A. R. G., Collins V. R., Plehwe W., Gareeboo H., Fareed D., Hemraj F., Taylor H. R., Tuomilehto J., Alberti K. G. M. M., Zimmet P. Z., Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. American Journal of Epidemiology 1998 147 5 448 457 2-s2.0-18144442999 (Pubitemid 28146104)
34. Vučić Lovrenčić M., Topić E., Hemoglobin A1c: standardizacija 'zlatnog standarda'. Biochemia Medica 2006 16 1 25 36
35. Demacker P. N. M., Boerma G. J. M., Baadenhuijsen H., Evaluation of accuracy of 20 different test kits for the enzymic determination of cholesterol. Clinical Chemistry 1983 29 11 1916 1922 2-s2.0-0020603512 (Pubitemid 13023978)
36. McGowan M. W., Artiss J. D., Strandbergh D. R., Zak B., A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clinical Chemistry 1983 29 3 538 542 2-s2.0-0020680990 (Pubitemid 13160770)
37. Kumanyika S. K., Obarzanek E., Stettler N., Bell R., Field A. E., Fortmann S. P., Franklin B. A., Gillman M. W., Lewis C. E., Poston W. C., Stevens J., Hong Y., Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for prevention (formerly the expert panel on population and prevention science). Circulation 2008 118 4 428 464 2-s2.0-49149109159 10.1161/CIRCULATIONAHA.108.189702
38. Aldington S. J., Kohner E. M., Meuer S., Klein R., Sjolie A. K., Methodology for retinal photography and assessment of diabetic retinography: The EURODIAB IDDM Complications Study. Diabetologia 1995 38 4 437 444 2-s2.0-0028938980 10.1007/s001250050303
39. KDOQI, KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. American Journal of Kidney Diseases 2007 49 supplement 2 2 S12 S154
40. Sokal R. R., Rohlf F. J., Biometry: The Principles and Practice of Statistics in Biological Researchedition 1995 3rd New York, NY, USA W. H. Freeman
41. StatSoft, Electronic Statistics Textbook 2011 Tulsa, Okla, USA StatSoft. http://www.statsoft.com/Textbook
42. Yau J. W. Y., Rogers S. L., Kawasaki R., Lamoureux E. L., Kowalski J. W., Bek T., Chen S.-J., Dekker J. M., Fletcher A., Grauslund J., Haffner S., Hamman R. F., Ikram M. K., Kayama T., Klein B. E. K., Klein R., Krishnaiah S., Mayurasakorn K., O'Hare J. P., Orchard T. J., Porta M., Rema M., Roy M. S., Sharma T., Shaw J., Taylor H., Tielsch J. M., Varma R., Wang J. J., Wang N., West S., Zu L., Yasuda M., Zhang X., Mitchell P., Wong T. Y., Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012 35 3 556 564 2-s2.0-84859030420 10.2337/dc11-1909
43. Romero-Aroca P., Baget-Bernaldiz M., Reyes-Torres J., Relationship between diabetic retinopathy, microalbuminuria and overt nephropathy, and twenty-year incidence follow-up of a sample of type 1 diabetic patients. Journal of Diabetes and Its Complications 2012 26 6 506 512
44. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993 329 14 977 986
45. Reichard P., Nilsson B.-Y., Rosenqvist U., The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. The New England Journal of Medicine 1993 329 5 304 309 2-s2.0-0027275397 10.1056/NEJM199307293290502 (Pubitemid 23210681)
46. Silha J. V., Krsek M., Sucharda P., Murphy L. J., Angiogenic factors are elevated in overweight and obese individuals. International Journal of Obesity 2005 29 11 1308 1314 2-s2.0-27944453623 10.1038/sj.ijo.0802987 (Pubitemid 41679261)
47. Aiello L. P., Avery R. L., Arrigg P. G., Keyt B. A., Jampel H. D., Shah S. T., Pasquale L. R., Thieme H., Iwamoto M. A., Park J. E., Nguyen H. V., Aiello L. M., Ferrara N., King G. L., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. The New England Journal of Medicine 1994 331 22 1480 1487 2-s2.0-0027942607 10.1056/NEJM199412013312203 (Pubitemid 24356306)
48. Praidou A., Androudi S., Brazitikos P., Karakiulakis G., Papakonstantinou E., Dimitrakos S., Angiogenic growth factors and their inhibitors in diabetic retinopathy. Current Diabetes Reviews 2010 6 5 304 312 2-s2.0-79952118441
49. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., Hashimoto N., Saito Y., Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003 46 11 1483 1488 2-s2.0-0345117960 10.1007/s00125-003-1221-6 (Pubitemid 37518569)
50. Haslam D. W., James W. P. T., Obesity. The Lancet 2005 366 9492 1197 1209 2-s2.0-25844457693 10.1016/S0140-6736(05)67483-1 (Pubitemid 41393598)
51. Libman I. M., Pietropaolo M., Arslanian S. A., LaPorte R. E., Becker D. J., Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 2003 26 10 2871 2875 2-s2.0-0141781111 10.2337/diacare.26.10.2871 (Pubitemid 37205561)
52. Tran B., Oliver S., Rosa J., Galassetti P., Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: an overview of ten years of studies. Experimental Diabetes Research 2012 2012 7 683680 10.1155/2012/683680
53. King G. L., The role of inflammatory cytokines in diabetes and its complications. Journal of Periodontology 2008 79 8 1527 1534 2-s2.0-49449117005 10.1902/jop.2008.080246
54. Keaney J. F. Jr., Larson M. G., Vasan R. S., Wilson P. W. F., Lipinska I., Corey D., Massaro J. M., Sutherland P., Vita J. A., Benjamin E. J., Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 3 434 439 2-s2.0-0037342568 10.1161/01.ATV.0000058402.34138.11 (Pubitemid 36337219)
55. Wong T. Y., Duncan B. B., Golden S. H., Klein R., Couper D. J., Klein B. E. K., Hubbard L. D., Sharrett A. R., Schmidt M. I., Associations between the metabolic syndrome and retinal microvascular signs: the atherosclerosis risk in communities study. Investigative Ophthalmology and Visual Science 2004 45 9 2949 2954 2-s2.0-4344667580 10.1167/iovs.04-0069 (Pubitemid 39121821)
56. McGill M., Molyneaux L., Twigg S. M., Yue D. K., The metabolic syndrome in type 1 diabetes: does it exist and does it matter? Journal of Diabetes and Its Complications 2008 22 1 18 23 2-s2.0-37749004882 10.1016/j.jdiacomp.2006.10. 005
57. Van Gaal L. F., Mertens I. L., De Block C. E., Mechanisms linking obesity with cardiovascular disease. Nature 2006 444 7121 875 880 2-s2.0-33845914986 10.1038/nature05487 (Pubitemid 46028447)
58. De Mattia G., Bravi M. C., Laurenti O., Moretti A., Cipriani R., Gatti A., Mandosi E., Morano S., Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications. Diabetes Research and Clinical Practice 2008 79 2 337 342 2-s2.0-38349117509 10.1016/j.diabres.2007.09.005
59. Fuentes E., Fuentes F., Vilahur G., Badimon L., Palomo I., Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators of Inflammation 2013 2013 11 136584 10.1155/2013/136584
60. Sierra-Honigmann M. R., Nath A. K., Murakami C., García- Cardeña G., Papapetropoulos A., Sessa W. C., Madge L. A., Schechner J. S., Schwabb M. B., Polverini P. J., Flores-Riveros J. R., Biological action of leptin as an angiogenic factor. Science 1998 281 5383 1683 1686 2-s2.0-0032508682 10.1126/science.281.5383.1683 (Pubitemid 28435586)
61. Uckaya G., Ozata M., Bayraktar Z., Erten V., Bingol N., Ozdemir I. C., Is leptin associated with diabetic retinopathy? Diabetes Care 2000 23 3 371 376 2-s2.0-0034007677 (Pubitemid 30131747)
62. Matsuda M., Kawasaki F., Yamada K., Kanda Y., Saito M., Eto M., Matsuki M., Kaku K., Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects. Diabetic Medicine 2004 21 8 881 888 2-s2.0-3843111317 10.1111/j.1464-5491.2004.01261.x (Pubitemid 39037002)
63. Tomić M., Ljubić S., Kaštelan S., The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy. Collegium Antropologicum 2013 37 supplement 1 51 57
64. Doumatey A. P., Zhou J., Huang H., Circulating adiponectin is associated with renal function independent of age and serum lipids in west Africans. Internal Journal of Nephrology 2012 2012 8 730920 10.1155/2012/730920
65. Habeeb N. M., Youssef O. I., Saab A. A., El Hadidi E. S., Adiponectin as a marker of complications in type I diabetes. Indian Pediatrics 2012 49 4 277 280
66. Astrup A. S., Tarnow L., Pietraszek L., Schalkwijk C. G., Stehouwer C. D. A., Parving H.-H., Rossing P., Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care 2008 31 6 1170 1176 2-s2.0-48649105081 10.2337/dc07-1960